1 256

Cited 103 times in

Efficacy of allergen-specific immunotherapy for atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials

Authors
 Jung Min Bae  ;  Yoon Young Choi  ;  Chang Ook Park  ;  Kee Yang Chung  ;  Kwang Hoon Lee 
Citation
 JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, Vol.132(1) : 110-117, 2013 
Journal Title
 JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 
ISSN
 0091-6749 
Issue Date
2013
MeSH
Bias ; Dermatitis, Atopic/therapy* ; Desensitization, Immunologic*/adverse effects ; Humans ; Randomized Controlled Trials as Topic
Keywords
Allergen-specific immunotherapy ; atopic dermatitismeta-analysis ; subcutaneous immunotherapy ; sublingual immunotherapy ; systematic review
Abstract
BACKGROUND: Allergen-specific immunotherapy (allergen-SIT) is the only treatment directed at the cause of IgE-mediated allergic diseases. However, there is controversy over the use of SIT for patients with atopic dermatitis. OBJECTIVE: We performed a systematic review and meta-analysis to assess the efficacy of SIT for patients with atopic dermatitis. METHODS: We performed manual searches of reference lists and computerized searches of the MEDLINE, EMBASE, CINAHL, Web of Science, and Cochrane databases (through December 10, 2012) for randomized controlled trials that compared SIT with placebo for patients with atopic dermatitis. The outcome of interest was a dichotomous variable, in terms of treatment success; a meta-analysis was performed by using a random-effects analysis. Subgroup analyses were carried out to evaluate the effects of long-term treatment (more than 1 year), SIT for severe atopic dermatitis, SIT for children, and subcutaneous and sublingual administration of immunotherapy. RESULTS: We analyzed 8 randomized controlled trials that comprised a total of 385 subjects. We found that SIT has a significant positive effect on atopic dermatitis (odds ratio [OR], 5.35; 95% CI, 1.61-17.77; number needed to treat, 3; 95% CI, 2-9). SIT also showed significant efficacy in long-term treatment (OR, 6.42; 95% CI, 1.50-27.52) for patients with severe atopic dermatitis (OR, 3.13; 95% CI, 1.31-7.48), and when administered subcutaneously (OR, 4.27; 95% CI, 1.36-13.39). CONCLUSIONS: A meta-analysis provides moderate-level evidence for the efficacy of SIT against atopic dermatitis. However, these findings are based on an analysis of a small number of randomized controlled trials, with considerable heterogeneity among trials.
Full Text
http://www.sciencedirect.com/science/article/pii/S0091674913004296
DOI
10.1016/j.jaci.2013.02.044
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Dermatology (피부과학교실) > 1. Journal Papers
Yonsei Authors
Park, Chang Ook(박창욱) ORCID logo https://orcid.org/0000-0003-3856-1201
Bae, Jung Min(배정민)
Lee, Kwang Hoon(이광훈)
Chung, Kee Yang(정기양) ORCID logo https://orcid.org/0000-0003-3257-0297
Choi, Yoon Young(최윤영) ORCID logo https://orcid.org/0000-0002-2179-7851
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/88130
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse